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NEW RESEARCHIdentifying Adolescents at Risk for Depression:
A Prediction Score Performance in Cohorts Based
in 3 Different Continents
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Luciana Anselmi, PhD, Louise Arseneault, PhD, Fernando C. Barros, MD, PhD,
Avshalom Caspi, PhD, Andrea Danese, MD, PhD, Helen Gonçalves, PhD, Hona Lee Harrington, BA,
Renate Houts, PhD, Ana M.B. Menezes, MD, PhD, Terrie E. Moffitt, PhD,
Valeria Mondelli, MD, PhD, Richie Poulton, PhD, Luis Augusto Rohde, MD, PhD,
Fernando Wehrmeister, PhD, Christian Kieling, MD, PhD
Objective: Prediction models have become frequent in the medical literature, but most published studies are conducted in a single setting. Het-
erogeneity between development and validation samples has been posited as a major obstacle for the generalization of models. We aimed to develop a
multivariable prognostic model using sociodemographic variables easily obtainable from adolescents at age 15 to predict a depressive disorder diagnosis at
age 18 and to evaluate its generalizability in 2 samples from diverse socioeconomic and cultural settings.
Method: Data from the 1993 Pelotas Birth Cohort were used to develop the prediction model, and its generalizability was evaluated in 2 repre-
sentative cohort studies: the Environmental Risk (E-Risk) Longitudinal Twin Study and the Dunedin Multidisciplinary Health and Development
Study.
Results: At age 15, 2,192 adolescents with no evidence of current or previous depression were included (44.6% male). The apparent C-statistic of the
models derived in Pelotas ranged from 0.76 to 0.79, and the model obtained from a penalized logistic regression was selected for subsequent external
evaluation. Major discrepancies between the samples were identified, impacting the external prognostic performance of the model (Dunedin and E-Risk
C-statistics of 0.63 and 0.59, respectively). The implementation of recommended strategies to account for this heterogeneity among samples improved
the model’s calibration in both samples.
Conclusion: An adolescent depression risk score comprising easily obtainable predictors was developed with good prognostic performance in a
Brazilian sample. Heterogeneity among settings was not trivial, but strategies to deal with sample diversity were identified as pivotal for providing better
risk stratification across samples. Future efforts should focus on developing better methodological approaches for incorporating heterogeneity in
prognostic research.
Key words: adolescent, cohort studies, depression, prognosis, risk assessment
J Am Acad Child Adolesc Psychiatry 2021;60(2):262–273.T
262he field of prognostic research has seen a sub-
stantial rise in publications of prediction
modeling studies in the last decade.1 This in-crease prompted significant advances in several medical
specialties.2,3 However, most published prognostic models
have been assessed in a single setting.4,5 Performance results
obtained from model-development studies are frequently
not achieved in validation trials when evaluated. This
inconsistency can be explained either by an overoptimistic
prognostic performance from an overfitted model or by
significant discrepancies between development and valida-
tion samples.6www.jaacap.orgWhen assessing external validation across datasets,
heterogeneity among prognostic studies is the norm rather
than the exception.7 Differences in assessment strategies,
frequency of outcome and/or studied factors, or availability
of variables of interest could impose considerable difficulties
for comparison purposes, impairing model generalizability.
Current methodological guidelines recommend a set of
careful development steps from derivation to external vali-
dation and ultimately use in clinical practice.8 In this pro-
cess, understanding the similarities and differences between
samples is essential,9 as guidelines suggest that a model with
poor external performance should be updated before beingJournal of the American Academy of Child & Adolescent Psychiatry
Volume 60 / Number 2 / February 2021
IDENTIFYING ADOLESCENTS AT RISK FOR DEPRESSIONdiscarded.6,10 This procedure integrates information obtained
from new data to the developed model, potentially improving
its prognostic ability.4,11 Even consolidated prediction
models, such as the Framingham score for cardiovascular
outcomes, face important drawbacks when applied in samples
somewhat diverse from the original,12 demanding model ad-
justments to enhance generalizability to different settings.4,6
Up to now, the majority of psychiatric composite
prognostic models studies have focused on model develop-
ment, with very few being adequately validated in inde-
pendent samples.13–15 In contrast to other areas of medicine,
where hard outcomes are more easily defined, imprecise
characterization of psychiatric outcomes imposes additional
barriers for accurate prognostic model development and
validation, as reliability of common mental disorders such as
depression has been shown to be low.16 Substantial hetero-
geneity in clinical presentation and high rate of comorbidity
produce additional obstacles for prediction of psychiatric
disorders, as different assessment strategies influence the
likelihood of endorsing a diagnosis.17
Prediction of psychosis, the most prolific and consoli-
dated area in prognostic psychiatry, has greatly advanced at
group level. However, it still faces challenges in prediction at
the individual subject level.18 Prediction of major depressive
disorder (MDD), the leading cause of mental health–related
disease burden globally, is still in its infancy, relying mainly
on single predictors for definition of at-risk people, with
only a few studies combining risk factors.19 Following
recently published standards for appropriate development
and validation of psychiatric prediction models,20 using the
most recent methodological recommendations1,6 and state-
of-the-art statistical strategies,21,22 the present study aimed
to derive and evaluate the generalizability of a psychiatric
prediction model across samples from different sociocultural
backgrounds.
Using data obtained from globally relevant longitudinal
population-based cohorts, our first goal was to develop a
multivariable prognostic model to evaluate the risk of
developing a depressive episode by late adolescence in a
Brazilian sample of adolescents with no evidence of previous
depression, using a priori selected, easily obtainable socio-
demographic variables collected directly from adolescents.
Our second goal was to evaluate the impact of heterogeneity
on its generalization to 2 diverse sociocultural contexts as
well as to assess strategies to overcome these limitations.
METHOD
Samples and Participants
We derived our prediction model using data exclusively
from the largest cohort available, the 1993 Pelotas Birth
Cohort, a prospective study set in Brazil, and thenJournal of the American Academy of Child & Adolescent Psychiatry
Volume 60 / Number 2 / February 2021evaluated the generalizability of findings in 2 diverse
samples: the Environmental Risk (E-Risk) Longitudinal
Twin Study, from the United Kingdom, and the Dunedin
Multidisciplinary Health and Development Study, from
New Zealand. Details about the 3 cohorts are reported
elsewhere23–25 and in Supplement 1, available online.
Briefly, in the Pelotas study, all 5,249 children born in the
city of Pelotas in 1993 were enrolled in the study. The
original goals of the 1993 Cohort were to evaluate trends
in maternal and child health indicators to assess associa-
tions between early life variables and later outcomes. At
the wave for ages 18–19 years old, the retention rate was
81.3% of the original sample. The Environmental Risk
(E-Risk) Longitudinal Twin study tracks the development
of a nationally representative birth cohort of 2,232 British
twin children born in England and Wales in 1994–
1995.20 The sample was constructed in 1999–2000, when
1,116 families with same-sex 5-year-old twins (93% of
those eligible) participated in home-visit assessments. The
Dunedin Study is a longitudinal investigation of health
and behavior in a complete birth cohort. All study par-
ticipants (N ¼ 1,037; 91% of eligible births; 52% male)
were born between April 1972 and March 1973 in
Dunedin, New Zealand.
To be included in the final analysis, an evaluation for a
depressive episode in late adolescence (18–19 years old) was
required. Exclusionary criteria were applied, filtering out
youths with intelligence quotient <70 and/or no signs of
puberty by 15 years of age. Additionally, as our intention
was to provide an alternative risk screening strategy beyond
using previous depressive episodes or subthreshold depres-
sive symptoms, participants with any suggestive evidence of
a current or previous MDD diagnosis by the age of risk
ascertainment were excluded from the final sample (see
Table S1, available online). As the E-Risk sample was not
evaluated at age 15, we selected the most comparable
assessment wave, namely, age 12. Given the age difference
at baseline between the E-Risk sample and the other sam-
ples, puberty was not considered an exclusionary criterion
for this sample.
Assessment and Definition of Predictor Variables
Selection of predictors was based on scientific literature
review and authors’ clinical expertise,26 but constrained to
their availability in the Pelotas dataset. As we aimed for real-
world implementation, following a pragmatic approach,27
we included variables readily available, not too costly to
obtain, and simple to evaluate.20,22 We adopted an a priori
defined criterion to use only variables directly obtained from
the adolescents in the Pelotas study at the age 15 assessment
wave to mirror the reality in routine practice, selecting 11www.jaacap.org 263
FIGURE 1 Flowcharts for Each Included Cohort Study
a
Available sample, n=1,920 
Eligible sample, n=1,450 
Depression 
screening index 
(OR rule for 5, 7, 
10 and 12 years 
assessment) 
IQ < 70, n=86 
Missing IQ information, 
n=57 
Positive screening for 
prior depressive 
symptoms, n=426 
Original E-Risk cohort, N=2,232 
Inclusion criterion: 
Individuals assessed for  
Major Depression at 18 years, 
n=2,063 
93% Retention rate at  
18 years assessment 
E-Risk cohort 
Missing data on 
covariates, n=306 
Missing prior depression 
screening data, n=44 
Included sample, n=1,144 
b
Inclusion criterion: 
Individuals assessed for 
Major Depression 





(OR rule for 11 
and 15 years 
assessment)
IQ < 70, n=31
Tanner stage < 2, 
n=58






Original Pelotas birth cohort, 
N=5,249
Failed to complete 
18/19 years 
assessment, n=54
Individuals located for 18/19 
years interview, n=4,106
81.3% Retention rate 
in 2011 (18/19 years)
Pelotas cohorta
Included sample, n=2,192
Missing data on 
covariates, n=269
Missing data on 
IQ and puberty 
criteria, n=477
Note: (a) Pelotas cohort. (b) E-Risk cohort. (c) Dunedin cohort.
aIn the Pelotas dataset, 5 excluded participants had both Tanner < 2 and IQ <70.
ROCHA et al.variables related to inherent characteristics (biological sex,
skin color), problematic behavior indicators (drug use,
school failure, social isolation, fight involvement), and
markers of household dysfunction (poor relationship with
mother, poor relationship with father, poor relationship
between parents, childhood maltreatment, ran away from
home). For comparison purposes, the harmonization of
selected variables among cohorts was performed a priori by
consensus among investigators from each site. Further de-
tails on variables’ assessment strategies are provided in
Table S1, available online.
Assessment and Definition of the Outcome Variable
In each sample, the outcome of interest was a categorical
diagnosis of depression in late adolescence. In the Pelotas
cohort, trained psychologists interviewed the participants at264 www.jaacap.orgages 18–19 years in 2011–2012 with a structured interview
for current MDD diagnosis using the Mini-International
Neuropsychiatric Interview (MINI) based on DSM-IV-TR
criteria, MDD section, assessing symptoms in the previous
2 weeks. For the E-Risk sample, MDD diagnosis in the
previous 12 months was assessed using the Diagnostic
Interview Schedule (DIS) at age 18 based on DSM-IV
criteria in 2012–2014. In the Dunedin cohort, past-year
MDD diagnosis was evaluated using the DIS at age 18
following DSM-III-R criteria in 1990–1991.
Statistical Analysis
A detailed description of statistical procedures used can be
found in Supplement 2, available online. In an effort to
enhance the reproducibility of our model, we transparently
described the process of model development and validation.Journal of the American Academy of Child & Adolescent Psychiatry
Volume 60 / Number 2 / February 2021
FIGURE 1 Continued
Inclusion criterion:  
Individuals assessed for  
Major Depression at 18 years, 
n=935 
Available sample, n=903 
Eligible sample, n=844 
Prior depression 
screening index 
(OR rule for 11, 
13 and 15 years 
assessment) 
IQ < 70, n=13 
Girls with no 
menarche  
by age 15, n=14  






Original Dunedin cohort, 
N=1,037 
95.8% Retention rate 
at 18 years 
assessment, n=993 
Dunedin cohort 
Included sample, n=739 
Missing data on 
covariates, n=105 
Missing data on  
IQ and puberty 
criteria, n=5 
c
IDENTIFYING ADOLESCENTS AT RISK FOR DEPRESSIONUsing data from the Pelotas cohort, we developed a baseline
model using binary logistic regression (LR) analysis—the
most common statistical strategy in prognostic research. As
overfitting is a major reason for irreproducibility, we derived
6 new models from the same dataset introducing different
strategies of model penalization—1 penalized LR model
using penalized maximum likelihood estimation (PMLE)
and 5 models with increasing degrees of penalization using
the Elastic-Net machine learning algorithm.21 Comparing
parameters of penalized models with our baseline model, we
selected for validation the one with more balanced perfor-
mance measures.
To evaluate the performance of the selected model in
new observations, we first internally validated it using
standard bootstrapping procedures to measure undueJournal of the American Academy of Child & Adolescent Psychiatry
Volume 60 / Number 2 / February 2021optimism in the model’s performance metrics, which hap-
pens when the model is evaluated directly in the derivation
cohort (apparent performance). Second, we quantified the
model’s prognostic performance in independent observa-
tions in 2 prospective cohorts from diverse contexts.
When assessing a given model’s prediction in inde-
pendent samples, its performance may be influenced by
differences between derivation and validation cohorts.6
Differences not only can be related to distribution of
participant characteristics (case mix), but also can be true
differences in predictor effects. To take this into account,
we adopted a sequence of recommended approaches.6,22 We
calculated a case mix–corrected and a refitted model for
each sample, and the obtained metrics were used as per-
formance parameters for each sample. Additionally, some of
the originally selected variables were not available in all the
cohorts, a likely situation in real-world model application.
Instead of excluding these variables, we evaluated the
amount of the original model’s information lost by this
mismatch.21 Finally, we evaluated the impact of between-
study heterogeneity by aggregating all cohorts into an
overall sample to model cohort differences either in baseline
risk or in predictor effects (see Supplement 3, available
online).28
All statistical analyses were performed using R 3.4.4
software (R Foundation for Statistical Computing, Vienna,
Austria). A complete-case analysis strategy was used,
excluding participants with any missing data. A multiple
imputation procedure using R package mice (R Foundation
for Statistical Computing) was applied to assess missing data
impact (see Table S2 and Figure S1, available online).
RESULTS
Sample Characteristics
A flowchart for each cohort is shown in Figure 1a–c. From
the original sample size of 5,249 adolescents in the Pelotas
cohort, 81.3% were retained up to the 18–19 years old
assessment, and 2,192 were included for final analyses after
applying exclusion criteria. For the E-Risk and Dunedin
samples, from the 2,232 and 1,037 initially assessed ado-
lescents, 1,144 (51.3%) and 739 (71.3%) were available for
assessment after exclusion criteria were applied, respectively.
Comparisons on key characteristics between retained and
excluded samples for the Pelotas cohort are provided in
Table S3, available online.
Table 1 presents descriptive variables for both depres-
sion outcome and selected predictors in each sample.
Noteworthy disparities were identified regarding rates of
school failure, social isolation, fight involvement, and
running away. Additionally, family relationships were not
assessed in the E-Risk Study. MDD prevalence in Pelotas,www.jaacap.org 265
TABLE 1 Sample Description for Each Cohorta
Pelotas (Brazil) E-Risk (United Kingdom)
Dunedin
(New Zealand)
Included sample 2,192 1,144 739
Assessment age, years 15 12 15
Male sex 977 (44.6)b 520 (45.5)b 375 (50.7)c
White skin color 1,478 (67.4)b 1,040 (90.9)c NAe
Childhood maltreatment
None 1,539 (70.2)b 963 (84.2)c 489 (66.2)d
Probable 390 (17.8) 139 (12.2) 187 (25.3)
Severe 263 (12.0) 42 (3.7) 63 (8.5)
School failure 1,127 (51.4)b 212 (18.5)c 80 (10.8)d
Social isolation 231 (10.5)b 63 (5.5)c 70 (9.5)b
Fights 211 (9.6)b 130 (11.4)b 12 (1.6)c
Ran away from home 80 (3.6)b 9 (0.8)c 49 (6.6)d
Any drug use 1,367 (62.4)b 569 (49.7)c 592 (80.1)d
Relationship with mother NA
Great 1,417 (64.6)




Relationship with father NA 22.0 ± 5.4f
Great 1,019 (46.5)




Relationship between parents NA
Great 886 (40.4)b 345 (46.7)c
Very good 421 (19.2) 278 (37.6)
Good 404 (18.4) 91 (12.3)
Regular 301 (13.7) 23 (3.1)
Bad 180 (8.2) 2 (0.3)
Depression prevalence 69 (3.1)b,g 202 (17.7)c,h 124 (16.8)d,h
Note: Results are shown as number of participants (percentage) for categorical variables and as mean  SD for continuous variables for participants
included in the final analyses. NA ¼ Data not available in the cohort.
aSee Table S1, available online, for assessment strategies applied to each cohort.
b–dSuperscript letters b, c, and d denote column differences among the samples: different letters show significant differences and the same letters
indicate nonsignificant differences from each other, assessed by c2 test at .05 level. For variables with more than 2 categories, the superscript letters
were placed in the first row of the variable and represent the assessment of the variable as a group, not per row.
eSkin color was not assessed in the cohort. Less than 7% of the cohort had any nonwhite ancestry.
fParent Attachment Scale score (range, 6 to 28)—adolescent assessment about the relationship with both parents.
gPresence of symptoms reaching diagnostic criteria within a 2-week period before assessment.
hPresence of symptoms reaching diagnostic criteria within a 12-month period before assessment.
ROCHA et al.E-Risk, and Dunedin samples was 3.1%, 17.7%, and
16.8%, respectively. Differences in outcome prevalence
among cohorts may have reflected differences in timeframe
for outcome assessment (2 weeks versus 12 months).
Model Development and Validation
Performance measures showed better results for models us-
ing LR strategies compared with machine learning Elastic-266 www.jaacap.orgNet approaches. In the Pelotas sample, discriminative ca-
pacity to parse between adolescents who later developed
depression at age 18 and those who did not, assessed by the
C-statistic, ranged from 0.76 to 0.79, indicating overall good
discrimination, as shown in Table 2.
Predictably, the baseline model showed the best com-
bination of performance metrics. Among penalized models,
the PMLE model demonstrated better performanceJournal of the American Academy of Child & Adolescent Psychiatry
Volume 60 / Number 2 / February 2021
TABLE 2 Apparent Performance Parameters Obtained From the Models Derived From the Pelotas Dataset
Model parameters
LR PMLEa Ridgeb .25b .50b .75b LASSOb
R2 0.15 0.12 0.12 0.10 0.10 0.10 0.10
LR c2c 81.90 66.17 63.30 54.40 54.32 54.71 54.10
Brier scored 2.88 2.93 2.93 2.95 2.95 2.95 2.95
C-statistice 0.79 0.78 0.78 0.76 0.76 0.76 0.76
Calibration slope 1.00 1.26 1.35 1.47 1.42 1.38 1.39
Note: Higher results for R2, LR c2, and C-statistic; lower results for Brier score; and results closer to 1 for calibration slope indicate better model
performance. .25 ¼ Elastic-Net with alpha ¼ .25; .50 ¼ Elastic-Net with a ¼ .50; .75 ¼ Elastic-Net with a ¼ .75; Brier score ¼ quadratic scoring rule that
combines calibration and discrimination; C-statistic ¼ concordance statistic, or area under the curve of the receiver operating characteristic; Cali-
bration slope ¼ measure of agreement between observed and predicted risk of the event (outcome) across the whole range of predicted values;
LASSO ¼ least absolute shrinkage and selection operator; LR ¼ logistic regression; LR c2 ¼ likelihood ratio c2; PMLE ¼ penalized maximum likelihood
estimation; R2 ¼ Nagelkerke’s R2; Ridge ¼ Ridge regression.
aThe penalty factor used in the PMLE was empirically obtained from our data.
bFor the Elastic-Net approach, we have a priori defined a grid of values for the hyperparameter a, ranging from 0 (full Ridge) to 1 (full LASSO), with
increments of 0.25. For each a value, a 10-fold cross-validation was used to select the penalty coefficient (l) that minimized the mean squared
prediction error, which was then used for shrinkage of coefficients and/or variable selection. See Table S4, available online, for model’s coefficients.
cAll LR c2 p values < .001.
dMultiplied by 102.
eThe C-statistic ranges from 0.5 for noninformative models to 1.0 for perfect models.
IDENTIFYING ADOLESCENTS AT RISK FOR DEPRESSIONcompared with all Elastic-Net models. As nonpenalized
models face a greater risk of overfitting, we proceeded to the
next step with both LR models for comparison. We inter-
nally validated each using bootstrapping evaluation with
1,000 iterations. As expected, measurement of optimism—
difference between apparent and bias-corrected performance
metrics—was lower for the PMLE model compared with
the LR model (DC-statistic: 0.067 versus 0.098;
Dslope: 0.004 versus 0.548; DR2: 0.034 versus 0.149),
suggesting lower overfitting and higher probability of
reliable results when applied to independent samples.
Additionally, as shown in Figure S2a–b, the PMLE model
was also more calibrated, with a 60% reduction in mean
square error compared with the LR model. Therefore,
the PMLE model was selected as the Pelotas final model,
with a C-statistic of 0.78 (bootstrap-corrected 95% CI:
0.73–0.82).
Using the most common external validation strategy,
the linear predictor derived from the selected Pelotas model
(Table S4, available online) was applied to the other sam-
ples. There was an expected decrease in the performance
metrics in both independent cohorts (E-Risk: C-statistic
0.59 [bootstrap-corrected 95% CI: 0.55–0.63]; Dunedin:
C-statistic 0.63 [bootstrap-corrected 95% CI: 0.59–0.67]).
The performance results for each step of the validation
process are presented in Table 3.
Model Updating
As variables from both independent datasets did not
perfectly pair with the set selected from the Pelotas study,Journal of the American Academy of Child & Adolescent Psychiatry
Volume 60 / Number 2 / February 2021we calculated the amount of information lost owing to this
mismatch.21 In the E-Risk dataset, 13.1% of original model
information was unavailable, mainly from the household
dysfunction indicators. In the Dunedin dataset, this per-
centage was lower, at around 6.9%.
Considering the relevant heterogeneity among cohorts,
we evaluated whether the integration of information from
the external cohorts could produce improvement in model
performance, in line with current methodological recom-
mendations.4 As differences in outcome prevalence were not
trivial, we updated the Pelotas model by correcting its
intercept for each cohort. In both validation samples, the
updated model produced better calibration, reducing all
measures of calibration error (Supplement 2 and
Figure S3a–d, available online).
Exploratory Analyses
The merger of all 3 cohorts into an aggregated sample to
assess between-cohort heterogeneity increased the total
number of participants to 4,075, of which 395 (9.7%)
demonstrated a positive outcome. Given that most of the
participants were from the Pelotas cohort (53.8%), the C-
statistic was also 0.78 (bootstrap-corrected 95% CI: 0.75–
0.80), but showed lower overfitting after internal validation
using bootstrapping (Figure 2a–b). Inclusion of each co-
hort’s main effects and their interaction terms with all
predictors into a PMLE model suggested that not only
disparities in case mix, as shown in Table 1, but also
between-cohort differences in predictor effects might have
influenced external validation results, particularlywww.jaacap.org 267





















C-statistic Concordance statistic, equal to
area under the curve of receiver
operating characteristic in
binary endpoints
0.78 0.71 0.59 0.66 0.62 0.63 0.68 0.67
Calibration-in-the-large Overall measure of calibration,
compares mean observed with
mean predicted in validation
dataset
0.00 0.02 2.37 0.02 0.00 2.26 L0.06 0.00
Calibration slope Measure of agreement between
observed and predicted risk of
event (outcome) across whole
range of predicted values
1.26 1.00 0.58 0.99 1.20 0.77 0.98 1.24
R2 Measure of overall goodness-of-
fit of model
0.12 0.06 0.03 0.04 0.05 0.05 0.05 0.09
Brier score Quadratic scoring rule that
combines calibration and
discrimination
0.03 0.03 0.17 0.02 0.14 0.16 0.02 0.13
Emax Maximum absolute error in
predicted probabilities
0.19 0.03 0.29 0.01 0.09 0.38 0.01 0.11
Available information for assessment of model performance 100% 86.9% 93.1%
Note: Higher results for C-statistic and R2, lower results for Brier score and Emax, results closer to 0 for calibration-in-the-large, and results closer to 1 for calibration slope indicate better
model performance.
aReference values indicating the model’s performance under the assumption that Pelotas model’s coefficients are fully correct for the validation setting, simulating similar case mix between
samples.22












































FIGURE 2 Performance Measures of the Aggregated Sample Model
a b
Note: (a) The area under the curve (AUC) of the receiver operating characteristic (ROC) curve and the bootstrapped 95% CI (indicated by gray shading) of the C-statistic,
and (b) calibration plot after internal validation using 1,000 iterations bootstrapping. Apparent and bias-corrected results were plotted as a nonparametric calibration curve,
estimated over a sequence of predicted values versus observed values using a smoothing technique.
IDENTIFYING ADOLESCENTS AT RISK FOR DEPRESSIONconsidering the difference in the ran-away and fight
involvement variables (Figure 3).DISCUSSION
Following current standards for psychiatric prognostic
research,20 our study proposes a multivariable model
developed in a Brazilian cohort to predict among adoles-
cents with no evidence of previous depression the risk of
developing a depressive episode in late adolescence. Our
model showed beyond chance results of discrimination and
calibration, with metrics comparable to established prog-
nostic models from other areas of medicine,3,29 and could
be viewed as a promising aid to adolescent depression risk
stratification.30
Evaluation in independent samples is deemed essential
for generalization of findings. Disparities among samples are
frequently seen as major obstacles for model validation,
replication, and generalizability. However, as the Trans-
parent Reporting of a multivariable prediction model for
Individual Prognosis Or Diagnosis (TRIPOD) statement
emphasizes, the term validation can be misleading, recom-
mending that an external validation should quantify the
model’s prognostic performance in a new sample, not
simply classifying it as a positive or negative valida-
tion.4,31,32 This broader validation approach not only pro-
motes the assessment of the model’s performance in the new
sample but also facilitates understanding of why the results
differ.Journal of the American Academy of Child & Adolescent Psychiatry
Volume 60 / Number 2 / February 2021For this study, we assessed the validation performance
of the model developed in our Brazilian sample in 2
population-based longitudinal cohorts from 2 different
continents. The development of a model in 1 middle-
income country and its external validation in samples rep-
resenting diverse sociocultural and economic contexts, using
different assessment strategies for data collection at different
time periods among them, may help evaluate if and where
its results can be generalized. Our results suggest that, albeit
adaptations should be applied to the original model to
enhance external clinical utility, the original prognostic
model could be applied in multiple other contexts despite
major differences in assessment strategies, socioeconomic
characteristics, and cultural influences. Given such pro-
found differences, it was expected that the developed model
could not be easily transported to new settings.9 Even
though lower in degree, our model kept a valid and beyond
chance prognostic capacity in parsing future risk of
depression among the adolescents in the independent co-
horts, especially when heterogeneity among samples was
accounted for (Supplement 3 and Figure S3a–d, available
online).
Early identification of people at higher risk for psychi-
atric disorders could potentially lessen the massive burden
imposed by these conditions. Positive family history of
depression and the presence of subthreshold depressive
symptoms have been the most commonly used criteria for
identifying at-risk children and adolescents.33 Although
these strategies have been replicated, reliance on singlewww.jaacap.org 269
FIGURE 3 Prognostic Contribution of Each Included Variable to the Aggregated Sample Prediction Model of Adolescent
Depression
Note: Comparison of the prognostic contribution of each included variable in each cohort to the aggregated sample prediction model of adolescent depression, stratified
by sex for Brazil, United Kingdom, and New Zealand cohorts. Predictors’ b coefficients from penalized logistic regression are shown as bars in the x-axis. Positive values
represent greater risk and negative values represent lower risk of the outcome. The results shown are derived from values presented in Table S5, available online. Some of
the variables previously included in the Pelotas model were excluded for comparability among datasets.
ROCHA et al.predictors restricts their prognostic contribution, not ac-
counting for a wider range of risk. Additionally, from a
pragmatic perspective, the requirement of trained staff for
proper evaluation of such predictors limits their potential
implementation, given that access to treatment has been
systematically highlighted as a major barrier for child and
adolescent mental health care.34
Our study has several strengths. We developed a
prognostic model for MDD according to most recent
guidelines in prognostic research and transparent report-
ing6,20 using modern, state-of-the-art statistical strate-
gies21,22 with broad external validation assessment.
Comprising only 11 predictors, all easily obtainable, quick
to assess, and collected directly from the adolescent, with no
need for highly specialized training, external informants, or
laboratory analyses, our results could be seen as promising if
further replicated. Additionally, consistent with the
evidence-based pragmatic psychiatry initiative,27 we opted
to prioritize simplicity over accuracy, selecting predictors270 www.jaacap.orgthat could be more easily and broadly implemented,
enhancing probability of future clinical use and patient
acceptance.
Significant limitations of our study also need to be
considered. Having based the development of our prog-
nostic model on the Pelotas cohort, an ongoing study not
primarily focused on mental health, availability of variables
of interest was limited to those previously collected, pre-
cluding the use of some potentially relevant factors. MDD
diagnosis was assessed at the age 18–19 years wave by
evaluating symptoms in the 2 weeks before the interview,
limiting comparability to other epidemiological cohort
studies as well as reducing the prevalence of the outcome of
interest. Consequently, the number of outcome events per
selected variable was lower in the Pelotas sample (events per
variable ¼ 6.27), increasing the risk of overfitting.20–22
Strategies such as machine learning regularization
methods, with shrinkage and selection of predictors as well
as measurement of performance optimism, wereJournal of the American Academy of Child & Adolescent Psychiatry
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IDENTIFYING ADOLESCENTS AT RISK FOR DEPRESSIONimplemented to constrain the impact of this limitation. The
proposed model is also not necessarily prognostic of earlier
or later onsets of depression.35 Furthermore, as we were
analyzing participants at higher risk of MDD diagnosis, we
could not discard the chance that all self-report assessments
were biased by this risk. Additionally, as our goal was to
provide a risk stratification tool that could be supplementary
to current strategies of risk evaluation, we opted to exclude
participants with any evidence of previous or current
depressive episodes because the occurrence of a depressive
episode already heightens the risk of subsequent depression.
This strategy resulted in a significant number of exclusions
that could have biased our findings; therefore, we compared
the covariates between included and excluded samples
(Table S3, available online), with anticipated differences
between them, and performed sensitivity analyses (see
Table S6 and Figure S4, available online) in which similar
performance results were identified.
The differences in predictors’ availability and assess-
ment strategies among cohorts are another relevant short-
coming, which could have influenced results obtained in the
external validations. The unavailability of assessment data at
age 15 in the E-Risk sample could have impacted the
comparability among the samples, as puberty is a well-
known risk contributor for depression,36 and could there-
fore have contributed to the performance result of the
model in that sample. A priori harmonization of variables
and measurement of information lost as a result of mis-
matching variables were applied to minimize the effect of
these limitations. Also, we were constrained to variables
assessed in each cohort study, which precluded important
predictors being included in our model, and the included
variables could be carrying prognostic information from
uncollected predictors, which could have contributed to
discrepancies in predictor effects shown in Figure 3. Finally,
in the present study, we could not evaluate the potential
impact of the developed model on clinical decision
making.20
Exploratory analyses suggested that information gener-
ated by our model increased prognostic ability above and
beyond established risk factors, such as subsyndromal
symptoms and a positive family history of depression
(Supplement 4 and Table S7, available online). At the same
time, the risk score was also associated, to a lesser degree,
with other diagnostic outcomes (C-statistic range: 0.64–
0.70) (Table S8, available online). In line with the current
literature on the early detection of psychopathology in
youth,37 we believe that a transdiagnostic approach could be
considered, despite its limitations,38 as specificity of psy-
chiatric prognostic models is likely to be low and as less
specific preventive interventions could promote meaningfulJournal of the American Academy of Child & Adolescent Psychiatry
Volume 60 / Number 2 / February 2021changes in psychiatric burden, either from individual or
public health perspectives.9,39
In conclusion, we present the development of a
prognostic model for MDD among Brazilian adolescents,
externally evaluated in 2 samples from diverse sociocultural
contexts using different strategies for data collection than
the original cohort. Heterogeneity among studies was high
and possibly accounted for major discrepancies in prog-
nostic performance, probably related not only to different
case mix but also to weight of coefficients.6 Future studies
should pursue methodological strategies for embracing
heterogeneity among samples, instead of avoiding it, thus
producing results that are more likely to be translated into
clinical practice across a range of contexts.Accepted January 8, 2020.
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Tecnologico (CNPq), Coordenaç~ao de Aperfeiçoamento de Pessoal de Nıvel
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ROCHA et al.Gonçalves, Menezes, Moffitt, Poulton, Rohde, Kieling
Methodology: Rocha, Fisher, Caye, Arseneault, Barros, Caspi, Danese,
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